BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2020
View Archived Issues
Recruitment of miR-8080 by luteolin as new therapeutic strategy in CRPC
Read More
Pancreatitis protein promotes pain
Read More
Rett gene affects maternal behavior via cortical plasticity
Read More
Norepinephrine is "unexpected connection" between amyloid and tau
Read More
BioTheryX initiates dosing in first-in-human phase I study of BTX-A51
Read More
LAM-002 shows antitumor activity in clinical setting and is to be evaluated as treatment of ALS
Read More
Medshine Discovery identifies isocitrate dehydrogenase mutant inhibitors
Read More
New liver X receptor alpha and beta inverse agonists discovered at Phenex-FXR
Read More
Roche, ETHZ disclose new cannabinoid CB2 receptor ligands
Read More
Adenosine A2A receptor antagonists identified at Zhejiang Vimgreen Pharma
Read More
ViiV Healthcare UK patents HIV integrase inhibitors
Read More
CADM1v8/9 variant useful to detect SCLC
Read More
Oncogenic FHL2-GLI2 fusion identified in sclerosing stromal tumors of the ovary
Read More
Evidence of activity seen in phase I trial of RMC-4630 in KRAS-mutant non-small cell lung cancer
Read More
Long-term safety and efficacy of AAV5-hFVIII-SQ gene therapy
Read More
Two new combination substudies evaluate pembrolizumab for NSCLC
Read More
PGAM1 inhibitor HKB-99 reduces non-small cell lung cancer tumor growth in vivo
Read More
Researchers discover compound with potential for EZH2-driven cancers
Read More
FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease
Read More
Amgen studies AMG-199 in patients with MUC17-positive gastric and GEJ cancer
Read More
Clene opens phase II study of CNM-Au8 in ALS
Read More
